| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,413,000 |
| Market
Cap: |
9.23(B) |
| Last
Volume: |
435,449 |
Avg
Vol: |
504,506 |
| 52
Week Range: |
$114.17 - $208.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
40,296 |
45,669 |
50,307 |
151,828 |
| Total Sell Value |
$7,357,263 |
$8,416,817 |
$9,119,818 |
$30,980,273 |
| Total People Sold |
2 |
4 |
5 |
6 |
| Total Sell Transactions |
3 |
5 |
7 |
17 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cooper Glenn L Md |
Director |
– • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,486 |
39,786 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2018-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
900 |
7,800 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2018-05-11 |
4 |
S |
$41.80 |
$835,936 |
D/D |
(20,000) |
94,957 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2018-05-11 |
4 |
OE |
$5.08 |
$101,600 |
D/D |
20,000 |
114,957 |
|
- |
|
| Barthelemy Nicholas |
Director |
– • – |
2018-05-09 |
4 |
S |
$40.54 |
$1,074,238 |
D/D |
(26,500) |
4,854 |
|
- |
|
| Barthelemy Nicholas |
Director |
– • – |
2018-05-09 |
4 |
OE |
$20.37 |
$576,800 |
D/D |
27,366 |
31,354 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2018-05-09 |
4 |
D |
$40.70 |
$56,980 |
D/D |
(1,400) |
259,393 |
|
- |
|
| Eddleman Roy T |
10% Owner |
– – • |
2018-05-09 |
4/A |
S |
$40.37 |
$1,850,972 |
I/I |
(45,773) |
430,000 |
|
- |
|
| Eddleman Roy T |
10% Owner |
– – • |
2018-05-09 |
4 |
S |
$40.37 |
$1,850,972 |
I/I |
(45,773) |
850,000 |
|
- |
|
| Eddleman Roy T |
10% Owner |
– – • |
2018-05-08 |
4/A |
S |
$40.66 |
$3,023,485 |
I/I |
(74,227) |
455,000 |
|
- |
|
| Eddleman Roy T |
10% Owner |
– – • |
2018-05-08 |
4 |
S |
$40.66 |
$3,023,485 |
I/I |
(74,227) |
875,000 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2018-03-08 |
4 |
S |
$36.16 |
$169,792 |
D/D |
(4,696) |
8,700 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2018-03-08 |
4 |
OE |
$3.22 |
$70,192 |
D/D |
4,696 |
13,396 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
186,005 |
260,793 |
|
- |
|
| Snodgres Jon |
CFO |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,680 |
35,654 |
|
- |
|
| Kuriyel Ralf |
Senior VP, R&D |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,643 |
12,605 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• • – |
2018-02-28 |
4 |
D |
$34.91 |
$308,051 |
D/D |
(8,825) |
74,788 |
|
- |
|
| Snodgres Jon |
CFO |
• – – |
2018-02-28 |
4 |
D |
$35.16 |
$86,843 |
D/D |
(2,470) |
24,974 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• • – |
2018-01-22 |
4 |
AS |
$35.95 |
$322,445 |
D/D |
(8,970) |
83,613 |
|
- |
|
| Eddleman Roy T |
10% Owner |
– – • |
2017-12-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,380,000 |
357,518 |
|
- |
|
| Benjamin Howard |
VP Business Development |
• – – |
2017-12-14 |
4 |
S |
$35.34 |
$449,835 |
D/D |
(12,729) |
33,908 |
|
- |
|
| Benjamin Howard |
VP Business Development |
• – – |
2017-12-14 |
4 |
OE |
$15.91 |
$305,663 |
D/D |
12,729 |
46,637 |
|
- |
|
| Snodgres Jon |
CFO |
• – – |
2017-07-18 |
4 |
D |
$41.77 |
$14,411 |
D/D |
(345) |
27,444 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,714 |
94,957 |
|
- |
|
| Cox John |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
4,827 |
|
- |
|
464 Records found
|
|
Page 14 of 19 |
|
|
1.26 (0.85%) 
